4893 items matching your search terms.

Concomitant CYP2D6 inhibitor use and plasma metabolite levels in breast cancer patients treated with tamoxifen

Fox, P Balakrishnar, B Menzies, A Liddle, C Coulter, S Provan, P Gebski, V Hui, R Kefford, R Wilcken, N Balleine, R Gurney, H

The case for more intensive use of statins

Fulcher, J. Keech, A.

Midregional pro-adrenomedullin predicts major coronary events and coronary death in patients stable after an acute coronary syndrome

Funke-Kaiser, A Colquhoun, D Mann, K Zeller, T Simes, J Sullivan, D Sydow, K West, M Blankenberg, S Tonkin, A and on behalf of the LIPID Study Investigators,

Modelling interrupted time series to evaluate prevention and control of infection in healthcare

Gebski, V Ellingson, K Edwards, J Jernigan, J Kleinbaum, D
EPIDEMIOLOGY AND INFECTION, 2012     DOI:10.1017/S0950268812000179

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial

Gladieff, L Ferrero, A De Rauglaudre, G Brown, C Vasey, P Reinthaller, A Pujade-Lauraine, E Reed, N Lorusso, D Siena, S Helland, H Elit, L Mahner, S
ANNALS OF ONCOLOGY, 2012     DOI:10.1093/annonc/mdr441

Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study

Goldstein, D Bennett, BK Webber, K Boyle, F de Souza, PL Wilcken, NRC Scott, EM Toppler, R Murie, P O’Malley, L McCourt, J Friedlander, M Hickie, IB Lloyd, AR

The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

Goldstein, D Spry, N Cummins, MM Brown, C van Hazel, GA Carroll, S Selva-Nayagam, S Borg, M Ackland, SP Wratten, C Shapiro, J Porter, IWT Hruby, G Horvath, L Bydder, S Underhill, C Harvey, J Gebski, VJ on behalf of the Australasian Gastro-Intestinal Trials Group,
BRITISH JOURNAL OF CANCER, 2012     DOI:doi:10.1038/bjc.2011.526

Accelerated BEP study update

Grimison, P

Accelerated BEP for metastatic germ cell tumors: combined analysis of Australian and UK phase I/II trials

Grimison, PS Chatfield, MD Mazhar, D Toner, GC Chester, J Thomson, DB Stark, D Stockler, MR Shamash, J Friedlander, M White, J Gebski, V Wason, J Boland, AL Rimmer, Y McDonald, A Gurney, H Rosenthal, M Singhal, N Williams, MV

Long-term safety and effectiveness of cholesterol lowering with pravastatin treatment over 11 years: the LIPID Study extension

Hague, W Simes, J Kirby, A Hunt, D Thompson, P Keech, AC Pater, H White, HD Colquhoun, D Tonkin, A

Systematic nonlinear relations between joint mechanics and the neural reflex response with changes in stretch amplitude at the wrist

Halakia, M O'Dwyer, N Cathers, I Heritier, S

Noncoding RNAs

Hardikar, AA Walker, MD Lynn, F
EXPERIMENTAL DIABETES RESEARCH, 2012     DOI:10.1155/2012/629249

Serum 25-hydroxy vitamin D: a predictor of microvascular and macrovascular complications in patients with type 2 diabetes

Herrmann, M Sullivan, DR McCorquodale, T Straub, IR Veillard, AS Keech, AC for the FIELD study investigators,

Plasma homocysteine and the risk of venous thromboembolism: Insights from the FIELD study

Herrmann, M. Whiting, M. J. Veillard, A. S. Ehnholm, C. Sullivan, D. R. Keech, A. C.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012     DOI:10.1515/cclm-2012-0078

Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study

Herrmann, M. Whiting, M. J. Veillard, A. S. Ehnholm, C. Sullivan, D. R. Keech, A. C. Field study investigators
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012     DOI:10.1515/cclm-2012-0078